Drug shortages
FDA drug-shortage determinations and their effect on supply, compounding and patient access.
- Editorial attention
- Emerging
- Tracked this week
- 1
- Sources this week
- 1
- Last activity
- 1 day ago
Signal strength reflects editorial attention across tracked sources — not medical certainty or strength of evidence.
- Pending editorial review
A system check is an automated check of the official sources, not a human review. An editorial review is recorded only when one of our editors has reviewed the page.
Drug shortages at a glance
- About this topic
- FDA drug-shortage determinations and their effect on supply, compounding and patient access.
- Current status
- No editor-reviewed status summary yet. The official records below update automatically.
- Last updated
- Primary sources
- Latest official record: Drug shortage update: Liraglutide Injection — Current (opens the source in a new tab) (U.S. Food and Drug Administration (Drug Shortages), Sep 21, 2026)
What’s the latest on Drug shortages?
0 totalNo briefings on this topic yet. Official records and trials below are updated continuously.
What do the official records show?
Primary sources and peer-reviewed research- Drug shortage update: Liraglutide Injection — Current (opens the source in a new tab)
Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13). Company: Novo Nordisk, Inc.. Estimated shortage duration: TBD
- Drug shortage update: Liraglutide Injection — Current (opens the source in a new tab)
Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12). Company: Novo Nordisk, Inc.. Estimated shortage duration: TBD
- Drug shortage update: Liraglutide Injection — Current (opens the source in a new tab)
Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22). Company: Novo Nordisk, Inc.. Distributed by Teva
- Drug shortage update: Liraglutide Injection — Current (opens the source in a new tab)
Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15). Company: Novo Nordisk, Inc.. Product will be available until discontinuation in January 2027
- Drug shortage update: Liraglutide Injection — Current (opens the source in a new tab)
Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20). Company: Novo Nordisk, Inc.. Distributed by Teva
- Drug shortage update: Liraglutide Injection — Current (opens the source in a new tab)
Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03). Company: Hikma Pharmaceuticals USA, Inc.
- Drug shortage update: Liraglutide Injection — Current (opens the source in a new tab)
Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02). Company: Hikma Pharmaceuticals USA, Inc.
- Drug shortage update: Liraglutide Injection — Current (opens the source in a new tab)
Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85). Company: Meitheal Pharmaceuticals, Inc.